Subscribe
Sign in
Home
Notes
Archive
About
Accelerating Drug Discovery with Transcriptomics: A Case Study
By using dense transcriptomic signatures of diseases matched with transcriptomic signatures of drugs, Transcripta is able to rapidly find effective new…
Sep 23
•
Transcripta Bio
1
May 2025
Transcripta Bio collaborates with Microsoft Research to Advance AI-Driven Disease-Gene Discovery
Palo Alto, CA – May 28, 2025 - Transcripta Bio today announced a research collaboration with Microsoft Research to accelerate the discovery of…
May 28
•
Transcripta Bio
2
Transcripta Bio's new visual brand language
Introducing Eigenfish: our new brand imagery
May 6
•
Transcripta Bio
and
Clayton Mellina
1
April 2025
Mastering the transcriptome with artificial intelligence
Chemo-transcriptomics at scale
Apr 16
•
Transcripta Bio
2
Transcripta Bio Named to the TIME100 Most Influential Companies of 2024
Palo Alto, Calif., May 30, 2024 – Transcripta Bio, a platform drug development biotechnology company that is revolutionizing discovering and developing…
Apr 16
•
Transcripta Bio
1
Unveiling Transcripta Bio
Today we are unveiling Transcripta Bio.
Apr 16
•
Transcripta Bio
1
Rarebase Names Chris Moxham as Chief Executive Officer
See full press release on PR Newswire.
Apr 16
•
Transcripta Bio
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
